Literature DB >> 15781195

Common polymorphisms in the PPARgamma2 and IRS-1 genes and their interaction influence serum adiponectin concentration in young Finnish men.

Firoozeh Mousavinasab1, Tuula Tähtinen, Jari Jokelainen, Pentti Koskela, Mauno Vanhala, Jorma Oikarinen, Sirkka Keinänen-Kiukaanniemi, Markku Laakso.   

Abstract

The Gly972Arg substitution of the insulin receptor substrate-1 (IRS-1) gene and the Pro12Pro genotype of the peroxisome proliferator-activated receptor gamma 2 (PPARgamma2) gene have been suggested to be associated with type 2 diabetes mellitus. In this study, the influence of these two polymorphisms on serum adiponectin concentrations was investigated. The Pro12Ala polymorphism of the PPARgamma2 gene and the Gly972Arg polymorphism of the IRS-1 gene were genotyped in 252 young Finnish servicemen. The Ala12Ala genotype of PPARgamma2 was associated with a higher adiponectin level compared to the Pro12Ala genotype (p=0.02) and the Pro12Pro genotype (p=0.02). Total (p=0.02) and low-density lipoprotein (LDL) cholesterol (p=0.03) levels were higher in subjects with the Pro12Pro genotype compared to the Pro12Ala genotype. No difference was observed in serum adiponectin level between the IRS-1 genotype groups. The subjects with X972Arg of this gene had high total and LDL cholesterol levels (p<0.05). The interaction between the PPARgamma2 and IRS-1 genes with respect to their effects on adiponectin levels was statistically significant (p=0.02). Adiponectin was significantly higher (p<0.05) in subjects who simultaneously had the Ala/Ala (PPARgamma2)+Gly/Gly (IRS-1) genotype combination compared to subjects with the Pro/Pro+Gly/Gly and Pro/Ala+Gly/Gly genotype combinations. Total and LDL cholesterol was higher (p<0.05) in subjects with Pro/Pro+X/Arg compared to subjects with the two before mentioned genotype combinations. We conclude that the Ala12Ala genotype of PPARgamma2 is associated with elevated adiponectin level, and that the PPARgamma2 and IRS-1 genes have a possible interaction in their effects on adiponectin concentration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781195     DOI: 10.1016/j.ymgme.2004.11.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  10 in total

Review 1.  Human genetics of adiponectin in the metabolic syndrome.

Authors:  Wei-Shiung Yang; Lee-Ming Chuang
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

2.  G Allele of the rs1801282 Polymorphism in PPARγ Gene Confers an Increased Risk of Obesity and Hypercholesterolemia, While T Allele of the rs3856806 Polymorphism Displays a Protective Role Against Dyslipidemia: A Systematic Review and Meta-Analysis.

Authors:  Shujin Li; Chuan He; Haiyan Nie; Qianyin Pang; Ruixia Wang; Zhifu Zeng; Yongyan Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

3.  Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms.

Authors:  Harvest F Gu
Journal:  Biomark Insights       Date:  2009-10-13

Review 4.  Pharmacogenetics of glucose-lowering drug treatment: a systematic review.

Authors:  Ozlem Bozkurt; Anthonius de Boer; Diederick E Grobbee; Eibert R Heerdink; Huib Burger; Olaf H Klungel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 5.  PPAR gamma and human metabolic disease.

Authors:  Robert K Semple; V Krishna K Chatterjee; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

6.  Association of the genetic variants of insulin receptor substrate 1 (IRS-1) with type 2 diabetes mellitus in a Saudi population.

Authors:  Khalid Khalaf Alharbi; Imran Ali Khan; Anjana Munshi; Fawiziah Khalaf Alharbi; Yazeed Al-Sheikh; May Salem Alnbaheen
Journal:  Endocrine       Date:  2014-02-04       Impact factor: 3.633

7.  Effect of the Pro12Ala polymorphism of the PPARg2 gene on serum adiponectin changes.

Authors:  Firoozeh Mousavinasab; Tuula Tähtinen; Jari Jokelainen; Pentti Koskela; Mauno Vanhala; Jorma Oikarinen; Sirkka Keinänen-Kiukaanniemi; Markku Laakso
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

8.  Proliferator-activated receptor gamma Pro12Ala interacts with the insulin receptor substrate 1 Gly972Arg and increase the risk of insulin resistance and diabetes in the mixed ancestry population from South Africa.

Authors:  Zelda Vergotine; Yandiswa Y Yako; Andre P Kengne; Rajiv T Erasmus; Tandi E Matsha
Journal:  BMC Genet       Date:  2014-01-21       Impact factor: 2.797

9.  Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism: a double blind, randomized, controlled cross-over study.

Authors:  J Herrmann; D Rubin; R Häsler; U Helwig; M Pfeuffer; A Auinger; C Laue; P Winkler; S Schreiber; D Bell; J Schrezenmeir
Journal:  Lipids Health Dis       Date:  2009-08-18       Impact factor: 3.876

10.  Insulin receptor substrate-1 (IRS-1) Gly927Arg: correlation with gestational diabetes mellitus in Saudi women.

Authors:  Khalid Khalaf Alharbi; Imran Ali Khan; Zeinab Abotalib; Malak Mohammed Al-Hakeem
Journal:  Biomed Res Int       Date:  2014-02-17       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.